{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:14:55Z","timestamp":1788243295152,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    Pro- and anti-coagulant factors are significantly altered in liver cirrhosis resulting in an increased bleeding and thrombosis risk. The thrombin generation (TG) test often seems unaltered in cirrhosis, indicating that a new hemostatic balance is reached. TG is determined by prothrombin conversion and thrombin inactivation. These processes can be quantified using the computational thrombin dynamics (TD) add-on analysis for the TG test. We studied TD parameters in cirrhosis to explore its predictive potential for bleeding and thrombosis. In the current study, 32 CP-A, 22 CP-B and 41 CP-C cirrhosis patients and 20 healthy controls were enrolled. Cirrhosis was predominantly alcohol-related (52%), while viral and metabolic etiologies accounted for 34% and 14% of cases, respectively. Patients receiving anticoagulant therapy were excluded. TG was measured using PPP Reagent Low in the presence and absence of thrombomodulin. TG peak height and velocity index were higher in patients than controls (+20%,p = 0.039 and +70%,p = 0.002), and time-to-peak was shorter (\u221218%,p &amp;lt; 0.0001). TD parameters were obtained computationally based on TG and coagulation factor data. The amount of prothrombin converted (PC\n                    <jats:sub>tot<\/jats:sub>\n                    ) was significantly reduced in patients (\u221243%,p &amp;lt; 0.0001), and the magnitude of the reduction was associated with disease severity. The maximum rate of prothrombin conversion (PC\n                    <jats:sub>max<\/jats:sub>\n                    ) showed a trend towards higher levels in CP-A patients. On the anticoagulant slide, the thrombin decay capacity (TDC) was significantly lower in patients (\u221244%,p &amp;lt; 0.0001), indicating a newly developed balance between pro- and anticoagulant processes that result in a slightly procoagulant TG phenotype. Four patients experienced bleeding and seven experienced thrombosis during follow-up (median = 499 days; CI: 478\u2013524 days). Low maximum prothrombin conversion rates (PC\n                    <jats:sub>max<\/jats:sub>\n                    ) were associated with an increased hazard of bleeding. Patients in the lowest 20% of PC\n                    <jats:sub>max<\/jats:sub>\n                    had a HR of 12.9 (95% CI 1.34\u2013124.31, p = 0.027) for bleeding. Low thrombin-\u03b1\n                    <jats:sub>2<\/jats:sub>\n                    Macroglobulin (T-\u03b1\n                    <jats:sub>2<\/jats:sub>\n                    M) complex formation was significantly associated with thrombosis during follow-up. Patients in the lowest quintile of T-\u03b1\n                    <jats:sub>2<\/jats:sub>\n                    M had a HR of 6.6 (95% CI 1.47\u201329.9, p = 0.014) for thrombosis. We conclude that reduced prothrombin conversion and thrombin inactivation result in rebalanced TG in cirrhosis patients. Our results demonstrate the potential clinical usefulness of TD parameters for the stratification of bleeding and thrombotic risk in cirrhosis patients.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2026.1764080","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:33:33Z","timestamp":1788240813000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombin dynamics and clinical events in cirrhosis: low prothrombin conversion predicts bleeding risk"],"prefix":"10.3389","volume":"14","author":[{"given":"Ruth Anne Laura","family":"Willems","sequence":"first","affiliation":[{"name":"Department of Functional Coagulation, Synapse Research Institute","place":["Maastricht, Netherlands"]},{"name":"Department of Internal Medicine, Maastricht University Medical Center","place":["Maastricht, Netherlands"]},{"name":"Thrombosis Expert Center Maastricht, Maastricht University Medical Center","place":["Maastricht, Netherlands"]},{"name":"Cardiovascular Research Institute, Maastricht (CARIM), School for Cardiovascular Diseases","place":["Maastricht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zanetto","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padova","place":["Padova, Italy"]},{"name":"Gastroenterology and Multivisceral Transplant Unit, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Campello","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), University of Padova","place":["Padova, Italy"]},{"name":"Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Konings","sequence":"additional","affiliation":[{"name":"Department of Functional Coagulation, Synapse Research Institute","place":["Maastricht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Bulato","sequence":"additional","affiliation":[{"name":"Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs","family":"Kramer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Maastricht University Medical Center","place":["Maastricht, Netherlands"]},{"name":"GROW\u2014School for Oncology and Reproduction, Maastricht University","place":["Maastricht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padova","place":["Padova, Italy"]},{"name":"Gastroenterology and Multivisceral Transplant Unit, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roest","sequence":"additional","affiliation":[{"name":"Department of Platelet Pathophysiology, Synapse Research Institute","place":["Maastricht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[{"name":"Gastroenterology and Multivisceral Transplant Unit, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padova","place":["Padova, Italy"]},{"name":"Gastroenterology and Multivisceral Transplant Unit, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo ten","family":"Cate","sequence":"additional","affiliation":[{"name":"Department of Functional Coagulation, Synapse Research Institute","place":["Maastricht, Netherlands"]},{"name":"Center of Thrombosis and Haemostasis, Gutenberg University Medical Center","place":["Mainz, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"de Vos-Geelen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Maastricht University Medical Center","place":["Maastricht, Netherlands"]},{"name":"GROW, Research Institute for Oncology and Reproduction, Maastricht University Medical Center","place":["Maastricht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[{"name":"Department of Functional Coagulation, Synapse Research Institute","place":["Maastricht, Netherlands"]},{"name":"Department of Data Analysis and Artificial Intelligence, Synapse Research Institute","place":["Maastricht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Simioni","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), University of Padova","place":["Padova, Italy"]},{"name":"First Chair of Internal Medicine and Thrombotic and Haemorrhagic Disease Unit, Padova University Hospital","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romy","family":"de Laat-Kremers","sequence":"additional","affiliation":[{"name":"Department of Data Analysis and Artificial Intelligence, Synapse Research Institute","place":["Maastricht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1160\/TH16-06-0450","article-title":"The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis","volume":"117","author":"Ambrosino","year":"2017","journal-title":"Thromb. Haemost."},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.1840060115","article-title":"Hemostasis and fibrinolysis in severe liver failure and their relation to hemorrhage","volume":"6","author":"Boks","year":"1986","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1111\/liv.15001","article-title":"Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"41","author":"Campello","year":"2021","journal-title":"Liver Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.thromres.2014.05.012","article-title":"Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event","volume":"134","author":"Chaireti","year":"2014","journal-title":"Thromb. Res."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69415-y","article-title":"Deciphering the coagulation profile through the dynamics of thrombin activity","volume":"10","author":"de Laat-Kremers","year":"2020","journal-title":"Sci. Reports"},{"key":"B6","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1160\/TH10-01-0040","article-title":"Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis","volume":"104","author":"Delahousse","year":"2010","journal-title":"Thromb. Haemost."},{"key":"B7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.dld.2011.10.016","article-title":"Bleeding and thrombosis in cirrhotic patients: what really matters?","volume":"44","author":"Ferro","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1373\/clinchem.2007.089144","article-title":"Novel serum biomarker candidates for liver fibrosis in hepatitis C patients","volume":"53","author":"Gangadharan","year":"2007","journal-title":"Clin. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1111\/j.1538-7836.2010.03937.x","article-title":"Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy","volume":"8","author":"Gatt","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"B10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.thromres.2014.07.010","article-title":"Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions","volume":"134","author":"Groeneveld","year":"2014","journal-title":"Thromb. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000073575","article-title":"The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability","volume":"32","author":"Hemker","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"B12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1423-0127-17-58","article-title":"Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI","volume":"17","author":"Ho","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/s0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1053\/j.gastro.2023.05.046","article-title":"Procedural-related bleeding in hospitalized patients with liver disease (PROC-BLeeD): an international, prospective, multicenter observational study","volume":"165","author":"Intagliata","year":"2023","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/jth.12706","article-title":"Cirrhosis patients have a coagulopathy that is associated with decreased clot formation capacity","volume":"12","author":"Kleinegris","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"B16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/jth.12798","article-title":"The balance of pro- and anticoagulant processes underlying thrombin generation","volume":"13","author":"Kremers","year":"","journal-title":"J. Thromb. Haemost."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0141491","DOI":"10.1371\/journal.pone.0141491","article-title":"Thrombin generating capacity and phenotypic association in ABO blood groups","volume":"10","author":"Kremers","year":"","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1160\/TH15-09-0716","article-title":"Low paediatric thrombin generation is caused by an attenuation of prothrombin conversion","volume":"115","author":"Kremers","year":"2016","journal-title":"Thromb. Haemost."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0177020","DOI":"10.1371\/journal.pone.0177020","article-title":"Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis","volume":"12","author":"Kremers","year":"2017","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1182\/bloodadvances.2018018036","article-title":"Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin","volume":"2","author":"Kremers","year":"2018","journal-title":"Blood Adv."},{"key":"B21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1055\/s-0040-1715102","article-title":"Thrombin generation and cirrhosis: state of the art and perspectives","volume":"46","author":"Lebreton","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"key":"B22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1440-1746.2009.05953.x","article-title":"Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B","volume":"25","author":"Lee","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000103655","article-title":"Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment","volume":"24","author":"Lisman","year":"2007","journal-title":"Dig. Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/s0168-8278(02)00199-x","article-title":"Haemostatic abnormalities in patients with liver disease","volume":"37","author":"Lisman","year":"2002","journal-title":"J. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jhep.2009.12.001","article-title":"Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests","volume":"52","author":"Lisman","year":"2010","journal-title":"J. Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.jhep.2021.11.004","article-title":"Haemostatic alterations and management of haemostasis in patients with cirrhosis","volume":"76","author":"Lisman","year":"2022","journal-title":"J. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ejh.13688","article-title":"The hemostatic and thrombotic complications of liver disease","volume":"107","author":"McMurry","year":"2021","journal-title":"Eur. J. Haematol."},{"key":"B30","first-page":"219","article-title":"The impact of operative bleeding on outcome in transplantation of the liver","volume":"176","author":"Mor","year":"1993","journal-title":"Surg. Gynecol. Obstet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","author":"Northup","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1538-7836.2007.02772.x","article-title":"Hypercoagulation and thrombophilia in liver disease","volume":"6","author":"Northup","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"B33","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjh.12462","article-title":"Decreased tissue factor pathway inhibitor (TFPI)-Dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels","volume":"162","author":"Potze","year":"2013","journal-title":"Br. J. Haematol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1134801","DOI":"10.3389\/fmed.2023.1134801","article-title":"Portal vein thrombosis in cirrhosis: a literature review","volume":"10","author":"Prakash","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.cgh.2023.04.016","article-title":"Bleeding and thrombotic complications in patients with cirrhosis: a state-of-the-art appraisal","volume":"21","author":"Rautou","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/liv.14404","article-title":"The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease","volume":"40","author":"Scheiner","year":"2020","journal-title":"Liver Int."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"B38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJMra003007","article-title":"Gastroesophageal variceal hemorrhage","volume":"345","author":"Sharara","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.jtha.2023.02.002","article-title":"Intraindividual variability over time of thrombin generation in patients with cirrhosis","volume":"21","author":"Sinegre","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"B40","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3949\/ccjm.89a.21018","article-title":"Cirrhotic coagulopathy: a rebalanced hemostasis","volume":"89","author":"Singh","year":"2022","journal-title":"Cleve Clin. J. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study","volume":"104","author":"S\u00f8gaard","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.thromres.2022.05.004","article-title":"Incidence and prevalence of venous thromboembolism in chronic liver disease: a systematic review and meta-analysis","volume":"215","author":"Subhani","year":"2022","journal-title":"Thromb. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2036.2007.03369.x","article-title":"Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease","volume":"26","author":"Tripodi","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","author":"Tripodi","year":"","journal-title":"J. Thromb. Haemost."},{"key":"B47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11739-011-0528-4","article-title":"Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma","volume":"7","author":"Tripodi","year":"","journal-title":"Intern Emerg. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jhep.2013.03.036","article-title":"Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis","volume":"59","author":"Tripodi","year":"2013","journal-title":"J. Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/qai.0000000000002633","article-title":"Plasmatic coagulation capacity correlates with inflammation and abacavir use during chronic HIV infection","volume":"87","author":"van der Heijden","year":"2021","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"B50","doi-asserted-by":"publisher","first-page":"a25346123","DOI":"10.1055\/a-2534-6123","article-title":"Risk of first venous thrombosis by comparing different thrombin generation assay conditions: results from the MEGA case-control study","volume":"9","author":"Winckers","year":"2025","journal-title":"TH Open"},{"key":"B51","doi-asserted-by":"publisher","first-page":"856754","DOI":"10.1155\/2013\/856754","article-title":"Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay","volume":"2013","author":"Youngwon","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","article-title":"Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation","volume":"78","author":"Zanetto","year":"2023","journal-title":"J. Hepatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.jtha.2023.10.008","article-title":"Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis","volume":"22","author":"Zanetto","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jhep.2024.12.008","article-title":"Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis","volume":"82","author":"Zanetto","year":"2025","journal-title":"J. Hepatol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1764080\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:33:34Z","timestamp":1788240814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1764080\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":54,"alternative-id":["10.3389\/fcell.2026.1764080"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1764080","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1764080"}}